KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $419.0 million.

  • Quest Diagnostics' Free Cash Flow rose 6760.0% to $419.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 3616.81%. This contributed to the annual value of $909.0 million for FY2024, which is 520.83% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Free Cash Flow is $419.0 million, which was up 6760.0% from $436.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Free Cash Flow registered a high of $645.0 million during Q1 2021, and its lowest value of -$33.0 million during Q1 2023.
  • Moreover, its 5-year median value for Free Cash Flow was $340.0 million (2023), whereas its average is $314.2 million.
  • As far as peak fluctuations go, Quest Diagnostics' Free Cash Flow plummeted by 10791.37% in 2023, and later surged by 29400.0% in 2025.
  • Over the past 5 years, Quest Diagnostics' Free Cash Flow (Quarter) stood at $337.0 million in 2021, then crashed by 44.51% to $187.0 million in 2022, then surged by 143.32% to $455.0 million in 2023, then fell by 25.05% to $341.0 million in 2024, then rose by 22.87% to $419.0 million in 2025.
  • Its Free Cash Flow stands at $419.0 million for Q3 2025, versus $436.0 million for Q2 2025 and $197.0 million for Q1 2025.